Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.
Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
FDA Accepts sNDA for Tapinarof Cream 1% for Treatment of Atopic Dermatitis
April 29th 2024The ADORING 3 phase 3 development program is currently studying the novel, aryl hydrocarbon receptor agonist as a once-daily, cosmetically elegant, and steroid-free topical cream for adults and children with atopic dermatitis.